Startseite/Aktien/GERN

GERN

USD

Geron Corporation Common Stock

$1.150-0.050 (-4.167%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.200

Hoch

$1.220

Tief

$1.140

Volumen

8.19M

Unternehmensfundamentaldaten

Marktkapitalisierung

733.7M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

7.83M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $1.09Aktuell $1.150Hoch $4.5

Ähnliche Nachrichten

4. Nov. 2025 · 13:00

BusinessWire

Geron Corporation to Present at Upcoming Investor Conferences

Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Harout Semerjian, Chief Executive Officer, is scheduled

Geron Corporation to Present at Upcoming Investor Conferences

3. Nov. 2025 · 14:05

BusinessWire

Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies

New analysis from the Phase 3 IMerge clinical trial, accepted as an oral presentation, explores relationship between treatment-emergent cytopenias and clinical response in LR-MDS Additional poster presentations